HOME › Research Insight › Key Players in the Bioburden Testing Market Focus on Acquisitions, New Product and Service Launches, and Expansions
Key Players in the Bioburden Testing Market Focus on Acquisitions, New Product and Service Launches, and Expansions
Key players in the global bioburden testing market include Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), SGS S.A. (Switzerland), WuXi PharmaTech (Cayman) Inc. (China), Merck & Co., Inc. (U.S.), Becton, Dickinson and Company (U.S.), North American Science Associates, Inc. (NAMSA) (U.S.), Nelson Laboratories (U.S.), Pacific Biolabs (U.S.), and ATS Labs, Inc. (U.S.).
Merck & Co., Inc. led the global bioburden testing market for bioburden testing instruments and consumables. The company has been active in this market for more than 40 years and has a strong brand image. It believes in organic growth strategies such as new product launches. In the past three years, the company launched many products, including EZ-Fluo rapid detection system, EZ-Fit Manifold, EZ-Pak Dispenser Curve, and EZ-Fit Filtration Unit. These launches helped the company to strengthen its existing portfolio of bioburden testing products and services.
The key strategies followed by most of the companies in the bioburden testing market are acquisitions, new product and service launches, and expansions. Acquisitions accounted for the largest share of the overall growth strategies mapped from 2012 to 2014. Some leading players that adopted this strategy are Charles River Laboratories International, Inc. (U.S.), Sigma-Aldrich Corporation (U.S.), and ATS Labs, Inc. (U.S).
Bioburden Testing Market by Product (Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)), by Test (Aerobic, Anaerobic, Fungi, Spore), by Application (Raw Material, In-process) & by End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252